RUZURGI
Identification of Ruzurgi
| No description |
Google image searchProduct monograph
Active ingredient
amifampridine, 10 MG
DIN: 02503034
Dosage form(s): TABLET
Route(s) of administration: ORAL
Description: IN ACCORDANCE WITH THE FCA DECISION IN A-78-22, THE 2021-06-24 DECISION (DATA PROTECTION) WAS RESTORED, AND A NEW NOC WAS ISSUED.
Schedule: Prescription
Company: MEDUNIK CANADA
Date: 24-JAN-2023
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07X — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD)
- N07XX — Other nervous system drugs (ATC, ATC/DDD)
- N07XX05 — AMIFAMPRIDINE (ATC/DDD)
